Cost Offset With Quadruple Therapy for Heart Failure

Дата публикации: 01-08-2026 00:00:00

This economic evaluation examines Medicare-linked registry data to estimate the 1-year health care cost offset and net cost associated with using quadruple guideline-directed medical therapy after hospitalization for heart failure with reduced ejection fraction.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Exercise Performance With Aficamten vs Metoprolol in oHCM	0	6.05	01-08-2026
2	Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk	0	7.22	01-08-2026
3	Twenty-Five–Year Follow-Up of Quantified Mitral Regurgitation	0	15.41	29-07-2026
4	Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy	0	7.02	21-07-2026
5	Right Ventricular Metrics as End Points in Clinical Trials	0	5.8	01-08-2026
6	Healthcare affordability	0	7.59	13-07-2026
7	Medicaid Expansion and 1-Year Mortality Among Young Adults Initiating Dialysis	0	10.89	01-08-2026
8	Are Load Flexible Technologies Affordable? A Population-Scale Cost-Benefit Analysis	0	11.04	13-08-2026
9	Экономия	0	0	20-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.43. Источник: archderm.jamanetwork.com.